• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尽管针对百日咳博德特氏菌蛋白的抗体水平下降,仍能在接种疫苗的儿童中识别出长期记忆 B 细胞。

Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins.

机构信息

Centre for Infectious Disease and Control (Cib), National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

出版信息

Vaccine. 2011 Feb 4;29(7):1431-7. doi: 10.1016/j.vaccine.2010.12.033. Epub 2010 Dec 25.

DOI:10.1016/j.vaccine.2010.12.033
PMID:21187178
Abstract

Whooping cough is a respiratory disease caused by Bordetella pertussis. Since the 1950s in developed countries pertussis vaccinations are included in the national immunization program. However, antibody levels rapidly wane after both whole cell and acellular pertussis vaccination. Therefore protection against pertussis may depend largely on long-term B- and T-cell immunities. We investigated long-term pertussis-specific memory B-cell responses in children who were primed at infant age with the Dutch wP-vaccine (ISRCTN65428640). Purified B-cells were characterized by FACS-analysis and after polyclonal stimulation memory B-cells were detected by ELISPOT-assays specific for pertussis toxin, filamentous haemagglutinin, pertactin and tetanus. In addition, plasma IgG levels directed to the same antigens were measured by a fluorescent bead-based multiplex immunoassay. Two and 3 years after wP priming as well as 2 and 5 years after the aP booster at the age of 4, low plasma IgG levels to the pertussis proteins were found. At the same time, however pertussis protein-specific memory B-cells could be detected and their number increased with age. The number of tetanus-specific memory B-cells was similar in all age groups, whereas IgG-tetanus levels were high 2 years after tetanus booster compared to pre- and 5 years post-booster levels. This study shows the presence of long-term pertussis protein-specific memory B-cells in children despite waning antibody levels after vaccination, which suggests that memory B-cells in addition to antibodies may contribute to protection against pertussis.

摘要

百日咳是由博德特氏菌引起的呼吸道疾病。自 20 世纪 50 年代以来,发达国家已将百日咳疫苗纳入国家免疫计划。然而,全细胞和无细胞百日咳疫苗接种后,抗体水平迅速下降。因此,对百日咳的保护可能在很大程度上依赖于长期的 B 细胞和 T 细胞免疫。我们研究了在婴儿时期接受荷兰 wP 疫苗(ISRCTN65428640)初次免疫的儿童中百日咳特异性记忆 B 细胞反应的长期情况。通过 FACS 分析对纯化的 B 细胞进行了特征描述,并用 ELISPOT 测定法检测针对百日咳毒素、丝状血凝素、 pertactin 和破伤风类毒素的多克隆刺激后的记忆 B 细胞。此外,还通过基于荧光珠的多重免疫分析法测量了针对相同抗原的血浆 IgG 水平。在 wP 初次免疫后 2 年和 3 年以及 4 岁时 aP 加强免疫后 2 年和 5 年,发现对百日咳蛋白的血浆 IgG 水平较低。然而,同时可以检测到百日咳蛋白特异性记忆 B 细胞,并且其数量随年龄增长而增加。所有年龄组的破伤风特异性记忆 B 细胞数量相似,而破伤风加强免疫后 2 年的破伤风 IgG 水平高于加强免疫前和 5 年后的水平。这项研究表明,尽管疫苗接种后抗体水平下降,但儿童体内仍存在长期的百日咳蛋白特异性记忆 B 细胞,这表明记忆 B 细胞除了抗体之外,可能有助于预防百日咳。

相似文献

1
Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins.尽管针对百日咳博德特氏菌蛋白的抗体水平下降,仍能在接种疫苗的儿童中识别出长期记忆 B 细胞。
Vaccine. 2011 Feb 4;29(7):1431-7. doi: 10.1016/j.vaccine.2010.12.033. Epub 2010 Dec 25.
2
Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.婴儿和学前百日咳疫苗接种对 4 岁儿童记忆 B 细胞反应的影响。
Vaccine. 2011 Aug 5;29(34):5725-30. doi: 10.1016/j.vaccine.2011.05.094. Epub 2011 Jun 12.
3
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.荷兰4岁儿童接种不同百日咳疫苗加强针后的IgG反应:疫苗抗原含量的影响。
Vaccine. 2009 Nov 5;27(47):6530-6. doi: 10.1016/j.vaccine.2009.08.052. Epub 2009 Sep 1.
4
Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.分别或联合接种白喉、破伤风、无细胞百日咳、乙型肝炎(DTa-HBV)和流感嗜血杆菌 b 型(Hib)疫苗进行基础和加强免疫是安全和具有免疫原性的。
Int J Infect Dis. 2010 Jan;14(1):e41-9. doi: 10.1016/j.ijid.2009.03.004. Epub 2009 May 20.
5
Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.与自然感染后相比,接种白喉、破伤风、三组分无细胞百日咳和乙肝联合疫苗进行初次免疫后的长期百日咳特异性免疫。
Infect Immun. 2001 Jul;69(7):4516-20. doi: 10.1128/IAI.69.7.4516-4520.2001.
6
Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age.儿童 9 岁时加强细胞性百日咳疫苗加强免疫后的记忆 B 细胞免疫应答。
Vaccine. 2011 Dec 9;30(1):51-8. doi: 10.1016/j.vaccine.2011.10.048. Epub 2011 Nov 4.
7
Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.一种新型五价白喉-破伤风-全细胞百日咳-乙型肝炎和B型流感嗜血杆菌疫苗的反应原性和免疫原性概况:Hib破伤风结合物含量的随机剂量范围试验
Pediatr Infect Dis J. 2006 Aug;25(8):706-12. doi: 10.1097/01.inf.0000223488.80814.df.
8
Humoral and B-cell memory responses in children five years after pertussis acellular vaccine priming.百日咳全细胞疫苗接种 5 年后儿童的体液和 B 细胞记忆应答。
Vaccine. 2014 Apr 11;32(18):2093-9. doi: 10.1016/j.vaccine.2014.02.005. Epub 2014 Feb 18.
9
Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.百日咳博德特氏菌特异性 B 细胞记忆的长期维持和功能受损。
Vaccine. 2010 Sep 14;28(40):6637-46. doi: 10.1016/j.vaccine.2010.06.118. Epub 2010 Jul 15.
10
Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.荷兰的一项开放标签、平行、随机对照试验:母亲百白破疫苗接种及其对 12 个月以下婴儿免疫应答的影响。
Lancet Infect Dis. 2019 Apr;19(4):392-401. doi: 10.1016/S1473-3099(18)30717-5. Epub 2019 Mar 27.

引用本文的文献

1
Serological responses to immunization during nephrosis in infants with congenital nephrotic syndrome of the Finnish type.芬兰型先天性肾病综合征患儿肾病期免疫接种后的血清学反应。
Front Pediatr. 2024 May 2;12:1392873. doi: 10.3389/fped.2024.1392873. eCollection 2024.
2
Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire.噬菌体展示测序揭示遗传、环境和内在因素影响人类抗体表位库的变异。
Immunity. 2023 Jun 13;56(6):1376-1392.e8. doi: 10.1016/j.immuni.2023.04.003. Epub 2023 May 9.
3
ADCC: An underappreciated correlate of cross-protection against influenza?
ADCC:流感交叉保护作用被低估的相关因素?
Front Immunol. 2023 Feb 22;14:1130725. doi: 10.3389/fimmu.2023.1130725. eCollection 2023.
4
The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings.全细胞百日咳疫苗在小鼠异源初免-加强免疫设置中引起广泛的效应 B 细胞反应。
JCI Insight. 2022 Nov 8;7(21):e157034. doi: 10.1172/jci.insight.157034.
5
Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.百日咳加强疫苗接种在三个国家四个年龄组中诱导记忆 B 细胞活化。
Front Immunol. 2022 May 23;13:864674. doi: 10.3389/fimmu.2022.864674. eCollection 2022.
6
Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination.年龄和初次疫苗接种背景影响浆细胞对百日咳加强疫苗接种的反应。
Vaccines (Basel). 2022 Jan 18;10(2):136. doi: 10.3390/vaccines10020136.
7
Vaccine-Induced Cellular Immunity against Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines.疫苗诱导的细胞免疫:借鉴动物和人体研究经验以改进新型百日咳疫苗的设计与测试
Vaccines (Basel). 2021 Aug 7;9(8):877. doi: 10.3390/vaccines9080877.
8
Evaluation of Anti-PT Antibody Response after Pertussis Vaccination and Infection: The Importance of Both Quantity and Quality.百日咳疫苗接种和感染后抗PT抗体反应的评估:数量和质量的重要性
Toxins (Basel). 2021 Jul 21;13(8):508. doi: 10.3390/toxins13080508.
9
Antibody Response to Pertussis Vaccination in Pregnant and Non-Pregnant Women-The Role of Sex Hormones.孕妇和非孕妇对百日咳疫苗接种的抗体反应——性激素的作用
Vaccines (Basel). 2021 Jun 10;9(6):637. doi: 10.3390/vaccines9060637.
10
Cost-Effectiveness of Pertussis Vaccination Schedule in Israel.以色列百日咳疫苗接种计划的成本效益
Vaccines (Basel). 2021 Jun 2;9(6):590. doi: 10.3390/vaccines9060590.